ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Finch Therapeutics’ C. Difficile drug gets breakthrough status pharmaceutical-technology
February 13, 2019Microbial therapies developer Finch Therapeutics has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for its investigational CP101 drug to treat recurrent Clostridium difficile (C. difficile) infection..... -
Finch Therapeutics Group Raises $36 Million in Series B Financing
firstwordpharma
March 02, 2018Finch Therapeutics Group, Inc. (Finch) announced today the successful close of an oversubscribed $36 million Series B financing, bringing the total capital raised since the Company's launch to $77 million.
Pharma Sources Insight January 2025
